MedPath

Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers

Conditions
Heart Failure
Equipment Failure
Arrhythmias
Thrombosis
Prosthesis-Related Infections
Interventions
Device: Laser sheath
Behavioral: Implantable Cardiac Device lead extraction
Registration Number
NCT03121183
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

The growing use and the expanding indications for cardiovascular implantable electronic devices (CIEDs) have been associated to an increase of device removal. The indications of CIEDs removal are infectious (55%) or noninfectious (45%) such as upgrading of devices, nonfunctional devices and thrombosis. Removal can be performed according to transvenous or surgical procedures. Transvenous lead removal (TLR) must be done by experimented cardiologists and respecting current consensus. TLR can be done with conventional techniques involving inserting locking stylets and telescoping sheaths around the pacing leads to separate them from the surrounding scar tissue. These conventional procedures have a success rate of ≈65%. TLR thanks to laser sheath has been validated and improved the success rate until \>95%. However, the TLR from chronically implanted CIEDs still carries a significant risk of procedural failure, morbidity, and mortality, related to tearing of the great vessels and cardiac structures, even when performed by experienced operators. Even if the transvenous extraction using laser sheath seems to be more effective, this strategy would be more expensive.

Considering the availability of several strategies for TLR and the cost heterogeneity of procedures, a cost assessment in real life of these therapeutic strategies is essential for an optimal choice of therapeutic strategies.

Detailed Description

The study will compare the strategies of percutaneous extraction to surgical extraction.

* Mechanical percutaneous extraction is the conventional technique using locking stylets and telescoping sheaths around the pacing leads to separate them from the surrounding scar tissue.

* Laser-assisted lead extraction is most often used in complex procedures and dissolves rather than tear the scar tissue.

* Sternotomy is the surgical procedure used when leads cannot be removed by percutaneous extraction. It is rarely employed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
45
Inclusion Criteria
    • Patients who have undergone an extraction of implantable pacemaker or defibrillator leads whatever the indication for the period march 2013-2017
Exclusion Criteria
    • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients who have undergone an extraction of implantable paceLaser sheath-
Patients who have undergone an extraction of implantable paceImplantable Cardiac Device lead extraction-
Primary Outcome Measures
NameTimeMethod
Direct medical costat day 1

Overall cost of care according to the hospital perspective: drug treatment, medical device, catheterization lab occupancy, operating room occupancy, medical and nursing staff time, hospitalization

Secondary Outcome Measures
NameTimeMethod
Investment cost for the hospital and dampingat day 1

annual projections: medical device and supplies

Type of interventionat day 1

mechanical percutaneous extraction, laser percutaneous extraction, surgical extraction

Indication of the interventionat day 1

infectious, technical failure or other

Extracted leads characteristicsat day 1

number, type, age, failure

Patient characteristicsat day 1

age, sex, origin (general hospital, university hospital, other)

Number and type of complicationsat day 1

tamponade, vascular rupture, haemothorax, equipment breakage, death...

percutaneous extractionat day 1

number of surgical transformation (sternotomy)

Duration of hospitalizationat day 1

pre and post-extraction

Duration of extraction procedure and fluoroscopyat day 1

for percutaneous extraction

quotation ranking of each patient for revenue valuationat day 1

quotation ranking of each patient for revenue valuation

Number of rehospitalizationat day 1

duration, cause and service

Trial Locations

Locations (1)

CHU Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath